Middle East Site Visit

RNS Number : 0619B

Mediclinic International PLC

15 June 2016

 

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

15 June 2016

Mediclinic International Middle East Site Visit

Mediclinic International plc ("Mediclinic" or the "Company"), a leading international private healthcare group, is today hosting a two day site visit of its Middle East platform. The event will be hosted by David Hadley, Chief Executive Officer of Mediclinic Middle East, and will include visits to several of the platform's hospitals and clinics in Abu Dhabi and Dubai, in addition to presentations on the Company's Middle East operations.

No new trading or financial information will be disclosed. Copies of the presentations will be made available on the Company's website: www.mediclinic.com 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International

Gert Hattingh, Executive Group Services

[phone]

Bell Pottinger

Liz Morley/Aarti Iyer/Lucy Stewart

[phone]

Notes:

Mediclinic is the world's third largest listed acute hospital operator (outside of the United States), with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective acute care specialised hospital services. The group operates 73 hospitals and 45 clinics.

Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE-listed private healthcare group based in the UK.

 

END

 

 

MSCAKNDQABKDDAD